Dr. Ekaterina Dobryakova, PhD
Claim this profileKessler Foundation
Studies Multiple Sclerosis
Studies Systemic Sclerosis
6 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Ekaterina Dobryakova, PhD is currently running
Delayed Feedback
for Parkinson's Disease
Learning deficits are frequent in individuals with Parkinson's Disease. Clear feedback is integral because through feedback individuals know whether they should stick with an action that they have been doing (if the feedback is positive), or change their course of action (if the feedback is negative). Learning though immediate feedback has been shown to be depended on the brain chemical dopamine that is disrupted in individuals with Parkinson's Disease. During learning, feedback can also be presented after a delay. The investigators propose that learning through delayed feedback will lead to greater learning in individuals with Parkinson's Disease, since learning through delayed feedback does not rely on dopamine. During the proposed paradigm, participants with Parkinson's Disease complete a multiple-choice test. After making their selection on the multiple-choice test, they either see feedback immediately or are given feedback 25 minute later after reviewing their selection on the multiple-choice test. The investigators hypothesize that participants will learn better when they are provided with delayed feedback.
Recruiting1 award N/A1 criteria
Feedback Timing During Learning
for TBI with Depression
The goal of this proposal is to examine the influence of feedback timing on learning and brain function in individuals with moderate-to-severe traumatic brain injury (TBI), with and without depression.
Recruiting1 award N/A8 criteria
More about Ekaterina Dobryakova, PhD
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Ekaterina Dobryakova, PhD has experience with
- Delayed Feedback
- Learning Through Feedback
- Ocrevus
- Tysabri
- Zeposia
- Placebo Control Exercises
Breakdown of trials Ekaterina Dobryakova, PhD has run
Multiple Sclerosis
Systemic Sclerosis
Fatigue
Parkinson's Disease
Traumatic Brain Injury
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ekaterina Dobryakova, PhD specialize in?
Ekaterina Dobryakova, PhD focuses on Multiple Sclerosis and Systemic Sclerosis. In particular, much of their work with Multiple Sclerosis has involved treating patients, or patients who are undergoing treatment.
Is Ekaterina Dobryakova, PhD currently recruiting for clinical trials?
Yes, Ekaterina Dobryakova, PhD is currently recruiting for 2 clinical trials in West Orange New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Ekaterina Dobryakova, PhD has studied deeply?
Yes, Ekaterina Dobryakova, PhD has studied treatments such as Delayed Feedback, Learning through feedback, Ocrevus.
What is the best way to schedule an appointment with Ekaterina Dobryakova, PhD?
Apply for one of the trials that Ekaterina Dobryakova, PhD is conducting.
What is the office address of Ekaterina Dobryakova, PhD?
The office of Ekaterina Dobryakova, PhD is located at: Kessler Foundation, West Orange, New Jersey 07052 United States. This is the address for their practice at the Kessler Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.